PharmaTher Holdings Ltd. (PHRRF)
USD 0.16
(-0.62%)
USD 0.16
(-0.62%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | -3.52 Million | -3.23 Million | -3.51 Million | 922.19 Thousand | -119.00 |
| Net Income | -3.11 Million | -6.41 Million | -4.01 Million | 2.66 Million | -23.81 Thousand |
| Depreciation & Amortization | 711.00 | 1422.00 | 1777.00 | 355.00 | - |
| Deferred income taxes | - | - | -185.5 Thousand | 185.5 Thousand | - |
| Stock-based compensation | - | - | 373.4 Thousand | 409.4 Thousand | 90 Thousand |
| Change in working capital | 16.55 Thousand | 546.3 Thousand | 176.45 Thousand | 186.08 Thousand | 8697.00 |
| Other non-cash items | -423.5 Thousand | 2.63 Million | 133.45 Thousand | -2.52 Million | 17.05 Thousand |
| Investing Cash Flow | -300 Thousand | - | - | 214.76 Thousand | - |
| Investments in PPE | - | - | - | -4265.00 | - |
| Acquisitions | - | - | - | 219.03 Thousand | - |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | -300 Thousand | - | - | - | - |
| Financing Cash Flow | 35 Thousand | - | 9.88 Million | 1.25 Million | 388.5 Thousand |
| Debt repayment | - | - | - | - | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | - | 9.88 Million | 1.25 Million | 388.5 Thousand |
| Other Financing Activities | 35 Thousand | - | 9.88 Million | 1.25 Million | 2.33 Million |
| Accounts receivables | 32.38 Thousand | -25.69 Thousand | -1514.00 | -26.59 Thousand | -2051.00 |
| Accounts payables | - | 561.99 Thousand | 194.18 Thousand | 204.04 Thousand | - |
| Inventory | - | 25.69 Thousand | 1514.00 | 26.59 Thousand | - |
| Other working capital | -15.82 Thousand | -15.69 Thousand | -17.73 Thousand | -17.96 Thousand | 10.74 Thousand |
| Cash at beginning of period | 5.91 Million | 9.15 Million | 2.77 Million | 388.38 Thousand | - |
| Cash at end of period | 2.13 Million | 5.91 Million | 9.15 Million | 2.77 Million | 388.38 Thousand |
| Capital Expenditure | - | - | - | -4265.00 | - |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -3.78 Million | -3.23 Million | 6.37 Million | 2.38 Million | 388.38 Thousand |
| Free Cash Flow | -3.52 Million | -3.23 Million | -3.51 Million | 917.92 Thousand | -119.00 |
| Breakdown | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -360.59 Thousand | -362.76 Thousand | -1.05 Million | -1.33 Million | -6.41 Million | -1.59 Million |
| Depreciation & Amortization | - | - | 356.00 | 355.00 | 1422.00 | 356.00 |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 34.58 Thousand | -339.87 Thousand | -248.79 Thousand | -69.45 Thousand | 546.3 Thousand | 345.59 Thousand |
| Other non-cash items | -4782.00 | -314.48 | 194.01 Thousand | 47.7 Thousand | 2.63 Million | 533.33 Thousand |
| Investing Cash Flow | - | - | - | -300 Thousand | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | -300 Thousand | - | - |
| Investment purchases | - | - | - | -300 Thousand | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | 300 Thousand | - | - |
| Financing Cash Flow | 35 Thousand | - | - | - | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 35 Thousand | - | - | - | - | - |
| Accounts receivables | 27 Thousand | -23.02 | 8047.00 | 20.35 Thousand | -25.69 Thousand | 6376.00 |
| Accounts payables | - | -294.12 Thousand | - | - | 561.99 Thousand | - |
| Inventory | - | - | - | - | 25.69 Thousand | - |
| Other working capital | 7583.00 | -22.72 | -256.84 Thousand | -89.8 Thousand | -15.69 Thousand | 339.21 Thousand |
| Cash at beginning of period | 2.42 Million | 3.15 Million | 4.26 Million | 5.91 Million | 9.15 Million | 6.63 Million |
| Cash at end of period | 2.13 Million | 2.42 Million | 3.15 Million | 4.26 Million | 5.91 Million | 5.91 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -295.79 Thousand | -722.98 Thousand | -1.11 Million | -1.65 Million | -3.23 Million | -714.76 Thousand |
| Free Cash Flow | -330.79 Thousand | -722.98 Thousand | -1.11 Million | -1.35 Million | -3.23 Million | -714.76 Thousand |
NSRCF
SHOORA
DC-A
BEC
APCOTEXIND
688767